A share price of AMGEN Inc [AMGN] is currently trading at $341.64, up 3.47%. An important factor to consider is whether the stock is rising or falling in short-term value. The AMGN shares have gain 3.94% over the last week, with a monthly amount glided 3.56%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Erste Group upgraded its rating to Buy on December 05, 2025. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $385 on November 13, 2025.
AMGEN Inc experienced fluctuations in its stock price throughout the past year between $259.35 and $346.38. Currently, Wall Street analysts expect the stock to reach $361.88 within the next 12 months. AMGEN Inc [NASDAQ: AMGN] shares were valued at $341.64 at the most recent close of the market. An investor can expect a potential return of 5.92% based on the average AMGN price forecast.
Analyzing the AMGN fundamentals
Trailing Twelve Months sales for AMGEN Inc [NASDAQ:AMGN] were 35.89B which represents 13.32% growth. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.96 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 5.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 334.81 points at the first support level, and at 327.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 345.76, and for the 2nd resistance point, it is at 349.88.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AMGEN Inc [NASDAQ:AMGN] is 1.28. On the other hand, the Quick Ratio is 0.99, and the Cash Ratio is 0.43. Considering the valuation of this stock, the price to sales ratio is 5.13, the price to book ratio is 19.13 and price to earnings (TTM) ratio is 26.41.
Transactions by insiders
Recent insider trading involved Grygiel Nancy A., SVP & CCO, that happened on Nov 20 ’25 when 3139.0 shares were sold. Officer, Grygiel Nancy A. completed a deal on Nov 20 ’25 to buy 3139.0 shares. Meanwhile, SVP, Business Development Khosla Rachna sold 890.0 shares on Nov 12 ’25.
